Program
tu-100
Also written as “TU-100” and “Daikenchuto Extract Granules (TU-100)”.
Its studies are mostly in Ileus · Irritable Bowel Syndrome · Crohn Disease, led by Tsumura USA.
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Tsumura USA | 51 open or running | phase 2since Dec 14, 2005 | Dec 14, 2005 | Jun 2028phase 2 · NCT07765589 |
Also a collaborator on its studies: icon-clinical-research.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Dec 14, 2005First study: phase 2 study in Postoperative IleusFirst studyNCT00266461 · 24 enrolled · United States
- Jul 5, 2011Phase 2 study in Crohn DiseaseNCT01388933 · 79 enrolled · United States
- Feb 24, 2014Phase 2 study in Irritable Bowel SyndromeNCT02074579 · 101 enrolled · United States
- Jan 29, 2021Phase 2 study in Enhanced Recovery After SurgeryNCT04742907 · 402 enrolled · United States
- Aug 6, 2026Phase 2 study in Delay in GI Recovery/Postoperative Ileus (POI)NCT07765589 · 240 planned
Ahead
- Jun 2028Primary completion: phase 2 study in Delay in GI Recovery/Postoperative Ileus (POI)NCT07765589
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 5 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07765589Delay in GI Recovery/Postoperative Ileus (POI) | 2 | Not yet recruiting | Jun 2028 | 240 |
| NCT04742907Enhanced Recovery After Surgery · United States | 2 | Completed | Mar 25, 2024 | 402 |
| NCT02074579Irritable Bowel Syndrome · United States | 2 | Completed | Apr 2016 | 101 |
| NCT01388933Crohn Disease · United States | 2 | Terminated | Sep 2013 | 79 |
| NCT00266461Postoperative Ileus · United States | 2 | Completed | Jan 2008 | 24 |
How it is read
Names in the registry
- “TU-100”, 4 entries
- “Daikenchuto Extract Granules (TU-100)”, 1 entry
Conditions, from the studies’ own filings
- Ileus, 2 studies
- Irritable Bowel Syndrome, 1 study
- Crohn Disease, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.